Please login to the form below

Not currently logged in
Email:
Password:

Napp names new managing director

Alberto Martinez joins from Mundipharma
Alberto Martinez Napp Pharmaceuticals

UK-based Napp Pharmaceuticals has appointed Alberto Martinez as the company's new managing director.

Martinez was most recently general manager of Mundipharma's operations in Spain where his successes included securing first place in Spain's 'Great Place to Work' survey for consecutive two years.

As Napp's new managing director he takes over from Dietmar Leitner who has been in the position since early 2012.

Martinez's previous experience includes time as marketing manager at Mundipharma's international operations and several years with Janssen.

He now moves to the growing life sciences hub of Cambridge in the UK where Napp is based.

“Napp has accomplished much over the years and clearly continues to succeed and grow as the healthcare landscape changes,” said Martinez. “I am committed to ensuring that Napp remains ambitious and agile so that we move from strength to strength in the years to come.”

25th November 2014

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...